By using octyl glucoside in the presence of glycerol, it is possible to obtain a solubilized malonyl-CoA-sensitive carnitine palmitoyltransferase (CPT,) 
INTRODUCTION
The inner and outer carnitine palmitoyltransferases (CPT, and CPT.) of mitochondria catalyse the interconversion of fatty acylCoAs to fatty-acylcarnitines and play a role in the mitochondrial transport of fatty acyl groups and in the regulation of fatty acid oxidation (Bremer, 1983; Pande, 1983; Bieber, 1988; McGarry et al., 1989) . We have recently shown that, whereas the malonylCoA-insensitive CPT, activity is known to be localized in the inner membrane, the malonyl-CoA-inhibitable CPT. is localized in the outer membrane of mitochondria (Murthy & Pande 1987a,b) . The question of whether these two CPT activities of mitochondria represent manifestations of the same or of different protein(s) is currently being debated (Miyazawa et al., 1983; Brady & Brady, 1987 Murthy & Pande, 1987a,b; Woeltje et al., 1987; Bieber, 1988; Zammit et al., 1988) .
Evidence supporting the distinct identities of the CPTO and CPT, activities may be summarized as follows. Whereas the subunit molecular mass of CPTi activity from liver and other tissues is estimated as 69 kDa (Bieber, 1988; McGarry et al., 1989 ; 80 kDa in Declercq et al., 1987) , tetradecylglycidyl-CoA, an irreversible inhibitor of the CPTO activity, was found to label a polypeptide of a higher subunit molecular mass. The latter was estimated as 94 kDa (Kiorpes et al., 1984) or 90 kDa (Declercq et al., 1987) in experiments with liver mitochondria, and about 86 kDa in experiments with muscle mitochondria (Declercq et al., 1987) . The possibility that the CPT. may be a protein of larger molecular mass than CPT, has been indicated also by irradiation-inactivation experiments; the initial estimates for CPTO and CPTi were about 96.7 and 69.7 kDa respectively in the experiments with liver mitochondria (Zammit et al., 1988) , but subsequent experiments, using mitochondrial outer membrane as the source of CPTO, have indicated a molecular mass of about 83 kDa for CPTO activity (Zammit et al., 1989) . Although immunological evidence has not been uniform, some polyclonal antibodies that could distinguish between the two mitochondrial CPT activities have been described (Brosnan et al., 1973; Declercq et al., 1987; Woeltje et al., 1987; Lilly et al., 1989 ).
An examination of the properties of the CPTO and CPT, in mitochondrial outer and inner membrane (Murthy & Pande, 1987b) has also supported the possibility of their being distinct entities. A clear-cut assessment of this, after solubilization and separation of the two CPT activities, has not been possible until now, although it had become known that under appropriate conditions a malonyl-CoA-sensitive CPT activity could be solubilized with octyl glucoside (Lund, 1987; Murthy & Pande, 1987b fractionated CPT0 activity, as reported previously (Murthy & Pande, 1987b) , but also its basal CPTO activity. We believe that these findings would aid in the further functional characterization of CPTO, an apparently transmembrane protein (Murthy & Pande, 1987a ). An abstract of some of these results has appeared (Murthy & Pande, 1988 Hajra & Bishop (1986) .
[3H]Etomoxir and unlabelled etomoxir-CoA were gifts from Dr. H. P. 0. Wolf, Byk-Gulden Pharmazeutika, Konstanz, Germany. 2-Tetradecylglycidyl-CoA was synthesized as described by Kiorpes et al. (1984) from 2-tetradecylglycidic acid, kindly supplied by McNeil Laboratories, Spring House, PA, U.S.A. Octyl glucoside was from Calbiochem.
Mitochondrial outer-and inner-membrane vesicle (OMV and IMV) preparations were as described previously (Murthy & Pande, 1987a,b) . Activity of CPT was assayed at 30°C either with 50 PM-[-1_4C]palmitoyl-CoA and 10 mM-carnitine as in Pande et al. (1986) , or with octanoyl-CoA and carnitine. In the latter case the assay system in 100,l contained 50 mM-potassium phosphate, pH 7.4, 50 jM-[1-14C]octanoyl-CoA and 10 mmcarnitine, and the reactions were stopped by the addition of 0.7 ml of a charcoal suspension [6.7 % (w/v) charcoal, 91 % (v/v) ethanol and 2% (v/v) H3P04]. After vortex-mixing and centrifugation (10000 g, 5 min), the supernatant was monitored for radioactivity corresponding to [1-14C] octanoylcarnitine. Because of the higher sensitivity, simplicity and rapidity of the latter assay procedure, in many experiments we have used [_-'4C] octanoyl-CoA as the substrate for monitoring the CPT activity and its inhibition by malonyl-CoA; our intermittent comparisons showed that the results obtained were similar to those with [1-14C]palmitoyl-CoA as the acyl-CoA substrate.
Purification of CPT,
Rat liver mitochondrial IMV were used as the starting material for this purification; the CPT activity of the IMV was not noticeably inhibited by up to 200 /M-malonyl-CoA, in agreement with that described earlier (Murthy & Pande, 1987b) . The IMV (5 mg of protein/ml) were extracted with a mixture containing 5 mM-potassium phosphate, pH 7.4, 5 % Tween-20, and protease inhibitors [leupeptin, 10 ,g/ml; pepstatin, 10,ug/ml; tosyllysylchloromethane (Tos-Lys-CH2CI), 50,ug/ml] for 20 min at 0-4 'C. After centrifugation at 150000 g for 1 h, the supernatant was applied to a DEAE-cellulose column (DE 52, Whatman) and the proteins were eluted with a linear gradient of 5-100 mmpotassium phosphate as described by Miyazawa et al. (1983) . Fractions with CPT activity were pooled, concentrated and equilibrated with 20 mM-potassium phosphate, pH 7.4, containing 2 % Tween-20 and protease inhibitors as above, and then applied to a hydroxyapatite h.p.l.c. column and the proteins were eluted with a 20-500 mM-potassium phosphate gradient. Fractions with CPT activity were eluted at about 260 mM-phosphate; these were combined, equilibrated with 25 mM-imidazole/HCl, pH 7.0, containing 0.5 % (10 ,ug/ml), Tos-Lys-CH2Cl (50 ,ug/ml), pepstatin (10 jug/ml) and OMV (1.2 mg/ml). Octyl glucoside was added last, to a final concentration of 40 mm. The ratio (w/w) of OMV protein to octyl glucoside was maintained at 1:10. The mixture was left at 0°C for 45 min and then centrifuged at 150000 g for 60 min.
CPT activity was found only in the supernatant. Approx. 1 ml of the above supernatant, containing about 1 mg of solubilized OMV protein, was applied to the hydroxyapatite h.p.l.c. column at 4°C, equilibrated in 100 mM-potassium phosphate, pH 7.4, containing 10% glycerol, 30 mM-octyl glucoside and protease inhibitors (leupeptin, 1 ,ug/ml; Tos-Lys-CH2Cl, 25,ug/ml; pepstatin, 1 ,ug/ml); the proteins were eluted with a 100 mM-l M gradient of potassium phosphate, pH 7.4, containing 30 mmoctyl glucoside, 10 % glycerol and the protease inhibitors. Fractions containing CPT activity emerged at around 260 mMphosphate (peak I) and at 500 mM-phosphate (peak II). These were separately pooled and their proteins concentrated by using Centriprep 30 (Amicon).
Reconstitution of CPT activities was done with asolectin liposomes. About 50 ,ug of protein of the test fraction was mixed with 2 mg of asolectin liposomes containing 100 mM-potassium phosphate, pH 7.4, and 0.1 mM-EDTA in a final volume of 400 #sl. This mixture was frozen on solid CO29 then thawed at 30°C and sonicated for 5 s at 4 'C. The resulting proteoliposomes were used the same day.
RESULTS AND DISCUSSION
It is generally accepted that mitochondria have two differentially localized CPT activities, that both exist in membrane-bound forms and that only one of them is sensitive to malonyl-CoA inhibition (Bremer, 1983) . After solubilization of liver and heart mitochondrial membranes with detergents, and purification, several workers have obtained only one protein with a subunit of 66-69 kDa having CPT activity (Bieber, 1988) . However, it has been observed by many that, once detached from the membranes with detergents, the resulting solubilized CPT does not show malonyl-CoA inhibition. Two interpretations have been offered from these results. The first assumes that a loss (dissociation) of a malonyl-CoA-inhibition-conferring peptide occurs on solubilization and that the catalytic activities of both mitochondrial CPT enzymes reside in the same protein (Bieber, 1988) . The second view ascribes these results to the detergentlability of the CPTO such that, after detergent solubilization of membrane proteins, the CPT activity that survives is the one derived exclusively from CPTp, the malonyl-CoA-insensitive enzyme of mitochondria (Woeltje et al., 1987; Lund, 1987; Murthy & Pande, 1987b) .
Unlike in the previous studies where, for purification of mitochondrial CPT, mitochondrial membranes having both malonyl-CoA-sensitive as well as insensitive CPT activities were subjected to detergent solubilization, in the present work we have tried to solubilize and fractionate the malonyl-CoA-sensitive and -insensitive CPT activities of liver mitochondria separately by proceeding with IMV as the exclusive source of the malonylCoA-insensitive CPT activity and with OMV as the exclusive source of the malonyl-CoA-sensitive one (Murthy & Pande, 1987b) . This has allowed us to follow the fate of the CPT, and CPT_ activities separately during their solubilization and subsequent fractionation. Our results have shown that from the IMV the malonyl-CoA-insensitive CPT activity could be purified to near-homogeneity as a protein with a subunit of about 66 kDa by using protocols as described by others (Miyazawa et al., 1983; Brady & Brady, 1987) ; this molecular-mass assignment is based on that of the BSA present in the Bio-Rad molecular-mass marker kit, with which the CPTi subunit co-migrated in the SDS/PAGE gels and which was assigned a mass of 66 kDa; others have mentioned the value for CPTi subunit as 68 kDa (Brady & Brady, 1987) or 69. 2 kDa (Miyazawa et al., 1983) . Our use of the hydroxyapatite h.p.l.c. step in the present work helped us to obtain a purer final preparation of CPTi, as monitored by, the SDS/PAGE separation and silver staining, than was otherwise possible. At this hydroxyapatite step, the CPT activity was eluted with 260 mM-potassium phosphate, and in high yields regardless of whether the detergent present was Tween-20 or octyl glucoside (results not shown).
The situation was quite different during the solubilization of the CPT., the malonyl-CoA-sensitive CPT activity, from OMV.
We have described previously that solubilization with a number of detergents led to a loss of this activity but that, under appropriate conditions, in the presence of 20% glycerol, by using octyl glucoside it was possible to obtain a malonyl-CoAsensitive CPT activity in the solubilized state, but with only about 50 % loss of activity (Murthy & Pande, 1987b) . Without glycerol the activity was lost nearly completely. For more effective solubilization and preservation of activity, we have since evaluated other detergents, different conditions of solubilization, and use of stabilizers described for labile membrane proteins, but none offered any improvement over the octyl glucoside/glycerol procedure mentioned above. In these experiments, using increasing ratios of detergents to protein, and by monitoring the CPT activity appearing in the 150000 g/60 min supernatant and that remaining with the residual pellet, we observed that a major activity loss and/or inactivation of CPT occurred instantly at the point of the enzyme detachment from the membrane, the extent of which varied with different detergents. then in the next 24 h at 0°C the activity declined to < 10 %. It is likely that, because of these losses, separation of proteins by several procedures, including affinity chromatography using CoA-or carnitine-coupled columns, did not yield fractions with increased CPTO specific activity. However, h.p.l.c. on hydroxyapatite column allowed the protein-fractionation step to be completed in less than 90 min and, despite lack of increase in the specific activity ofCPT0, yielded a clear separation ofthe malonylCoA-sensitive from the malonyl-CoA-insensitive activity for the first time. This has allowed further characterization of the two mitochondrial CPT activities and, as described below, these results have strongly supported the possibility of CPT1 and CPTbeing distinct proteins. Fig. 1 shows that the solubilized preparations of OMV on hydroxyapatite -h.p.l.c. fractionation yielded two CPT activity peaks, the first of which was eluted at about 260 mm-and the second at about 500 mM-potassium phosphate. When IMV were similarly solubilized and fractionated, all the CPT activity was eluted as a single peak near 260 /tM-potassium phosphate (results not shown). From this and other evidence (see below) we have concluded that the peak-I activity represented CPT,, whereas peak-II CPT activity was due to CPT.; clearly these proteins had different surface charges, inasmuch as their retention times on the hydroxyapatite column varied. Although the peak-I CPT activity accounted for < 10 % of the peak-II activity, the former corresponded to the presence ofless than 1 % oftotal CPT activity in the OMV, as illustrated below. Thus about 50 % of the CPTO activity of the OMV was lost at the octyl glucoside/glycerol solubilization step and the combined CPT activity of peaks I and II accounted for only about ith of that applied on the hydroxyapatite column. If we assume that the malonyl-CoAinsensitive CPT, activity did not undergo any loss in these steps, as was observed during comparable processing of the IMV, then the peak-I activity is calculated as (50/100) x (1/6) x (1/10) x 100 = 0.8 % of the total OMV CPT activity. This could easily have come from the presence of IMV as a minor contaminant in the OMV. Other evidence that the peak II activity represented CPTO may be summarized as follows.
First, the peak-II activity proved very labile, unlike the peak-30 Fraction no. Fig. 1 Vol. 268 Second, the peak-TI CPT activity was inhibited by malonylCoA, but that of peak I was not (Table 1 ). We have previously described that the octyl glucoside solubilization of CPTO led to a marked decrease in its malonyl-CoA-sensitivity, and that this was increased by the reconstitution of the CPTO into asolectin liposomes (Murthy & Pande, 1987b) . We have made similar observations in the present experiments; thus, whereas 20 /Mand 100 /sM-malonyl-CoA inhibited the membrane-bound CPTO activity by 80 and 95 % respectively, the corresponding inhibition was only 38 and 66% for the CPT activity of peak II before reconstitution, and 76 and 81 % after reconstitution. In the present series, we found that reconstitution markedly increased the basal activity also (Table 1) . Overall these results were about the same regardless of whether the reconstitution was by freeze-thaw and sonication or by detergent dialysis. Importantly, reconstitution had no effect on the basal CPT activity of the peak-I fractions or its insensitivity to malonyl-CoA inhibition.
These results indicate not only that phospholipid housing is important for the optimal expression of the regulatory property of CPTO, as was observed by Murthy & Pande (1987b) , but that this may apply also to the basal activity of CPTO. This indicates that the marked loss of basal CPTO activity and its malonyl-CoA inhibition on detergent solubilization resulted, at least in part, from the separation of the CPTO from its lipid environment in situ.
Third, Table 1 shows that at low micromolar concentrations both tetradecylglycidyl-CoA and etomoxir-CoA, known potent and selective inhibitors of CPTO of mitochondria, inhibited the CPT activity of peak II, but not that of peak I.
Fourth, Table 2 shows that polyclonal anti-(rat liver CPTi) antibody effectively precipitated the CPT activity present in the octyl glucoside-solubilized supernatants of IMV as well as of peak I, but under matching conditions it had no such effect on the CPT activity in the octyl glucoside supernatants derived from OMV or that of peak II activity. In a previous preliminary report, we described similar results with anti-(bovine liver CPT) antibody and that the octyl glucoside-solubilized CPTO activity was not precipitated by the antibody to the peroxisomal CPT (Murthy & Pande, 1988) . It is known that CPT1 is immunologically different from the peroxisomal CPT (Healy et al., 1988; Ramsay, 1988 Fig. 2 . Fluorography of SDS/PAGE-separated outer-membrane proteins from rat liver, heart and skeletal-muscle mitochondria after exposure to I3Hjetomoxir, CoA and ATP-Mg OMV (25 ,ug of protein) from liver, heart and skeletal-muscle mitochondria were exposed to [3H]etomoxir under conditions described for Fig. 1 , but in 50,ul final volume. After labelling, the outer-membrane pellet was dissolved directly in SDS/PAGE sample buffer and processed for SDS/PAGE as described by Laemmli (1970) . After electrophoresis, the gel was processed for fluorography by using Amplify according to the manufacturer's (Amersham) instructions, by using an X-ray film (Kodak X-OMAT RP) and exposure time of 24 h at -70 'C. Lanes: A and D, liver OMV; B, heart OMV; C, skeletal-muscle OMV. Positions of molecular-mass standards (kDa) 
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A clear correspondence between the labelled polypeptide and the CPTO activity has now been obtained, as described below.
We observed that, after incubation of OMV with [3H]etomoxir, the CoA ester of which is another irreversible inhibitor of CPTO (Wolf & Engel, 1985; Declercq et al., 1987) , along with ATP, MgCl2 and CoA, a 90 kDa polypeptide became labelled in the case of liver OMV and a 86 kDa polypeptide in the case of skeletal-muscle and heart mitochondrial OMV (Fig. 2) . No such protein labelling was observed with liver IMV (results not shown; however, see Fig. 3a, lane C) . These results were in line with those of Kiorpes et al. (1984) and Declercq et al. (1987) , and showed further that the subunit molecular mass of the labelled polypeptide was the same for heart and skeletal-muscle mitochondria. To examine the relationship of the labelled peptide to the CPT activity of the OMV, we incubated liver OMV with [3H]etomoxir under conditions where only about 10 % of the CPTO activity was inhibited. These labelled OMV were solubilized, subjected to hydroxyapatite h.p.l.c. and the fractions were monitored for CPT activity and 3H radioactivity and processed for SDS/PAGE and fluorography. These analyses showed that, of the four 3H radioactivity peaks in Fig. 1 , only the one eluted near 500 mmpotassium phosphate, in the same region as the CPT., had a polypeptide (90 kDa) that bound radioactivity. The radioactivity of the other three peaks moved ahead of polypeptide bands on SDS/PAGE (with the dye front), and most likely resulted from left-over unreacted [3Hletomoxir and its metabolites, such as
[3H]etomoxir-CoA, produced in the incubation system containing OMV, ATP, CoA etc. Furthermore, we observed that the intensity of the radioactive labelling of the 90 kDa polypeptide in the individual fractions of peak II closely matched the elution profile of the CPTO activity (Fig. 3a) . Prolonged exposure of the SDS/PAGE gel to the X-ray film (more than 4-5 days) during fluorography led to the appearance of other minor polypeptide bands, of which a 45 kDa polypeptide was more prominent (results not shown). SDS/PAGE of the peak-II fractions and silver staining showed that there was an enrichment of the 90 kDa polypeptide in the fractions with the highest CPT0 activity. However, many other polypeptides, including a major 60 kDa polypeptide, were also present in these fractions (Fig.  3b) . In the earlier stage of these studies, as described in an abstract (Murthy & Pande, 1988) , only one CPT activity peak was obtained by using a hydroxyapatite h.p.l.c. column (from Rainin, Woburn, MA, U.S.A.), which on SDS/PAGE showed a major 77 kDa and a minor 60 kDa polypeptide on Coomassie Blue staining. However, in the later work, as described here, refinement of conditions using another hydroxyapatite column (from Toyosoda, Tokyo, Japan) and silver staining have given substantially different results. In recent experiments, Zammit et al. (1989) 
